ResMed
361 hedge funds and large institutions have $5.47B invested in ResMed in 2016 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 133 increasing their positions, 132 reducing their positions, and 53 closing their positions.
337% more call options, than puts
Call options by funds: $22.8M | Put options by funds: $5.22M
1% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 132
1.44% less ownership
Funds ownership: 63.94% → 62.5% (-1.4%)
3% less funds holding
Funds holding: 373 → 361 (-12)
6% less capital invested
Capital invested by funds: $5.79B → $5.47B (-$326M)
15% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 53
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$145M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$22.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$16M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$63.5M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$38.6M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$23.8M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$20.7M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$17.4M |
RMD Hedge Fund Activity: Q4 2016 in Review
361 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2016, worth a combined $5.47B — down 5.6% from $5.79B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of RMD and 45 opened new positions — a net loss of 8 holders — while 132 trimmed existing stakes and 133 added.
The largest buyer was Capital World Investors, adding an estimated $145M. The largest seller was Renaissance Technologies, cutting an estimated $63.5M.
- 361 institutional investors held ResMed (RMD) as of Q4 2016, down from 373 in Q3 2016.
- Funds reported $5.47B of ResMed stock for Q4 2016, down 5.6% quarter-over-quarter.
- 45 funds opened new ResMed positions in Q4 2016 and 53 closed out, a net change of -8 holders.
- The largest ResMed buyer in Q4 2016 was Capital World Investors, an estimated $145M added.
- The largest ResMed seller in Q4 2016 was Renaissance Technologies, an estimated $63.5M sold.
Based on aggregated 13F filings for Q4 2016.